In this Issue:
Treating GT3 HCV infection with advanced liver disease
Why do vaccine-induced T cells fail to control HCV viraemia?
Immunotherapeutic vaccine for HCV disappoints
Cost-effectiveness of strategies to prevent perinatal HBV transmission
Use nucleos(t)ide analogues following RFA for HCC
Discontinuing oral antivirals in chronic HBV
Daclatasvir/sofosbuvir/ribavirin in advanced cirrhotic and post-transplant GT3 HCV
HCV reinfection in PWID after earlier SVR
PegIFN-l vs PegIFN-α in HBeAg+ chronic HBV
The role of canonical NF-kB signalling in HCC development
Please login below to download this issue (PDF)